FDA Approves First Oral Medication to Increase Platelet Production for ITP Patients

GlaxoSmithKline recently announced that PROMACTA(R) was approved for the treatment of thrombocytopenia in patients with ITP.  Read entire article, including CCBF Dr. Bussel’s thoughts on this breakthrough.